BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 21 2018 - 8:00AM
BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading
commercial specialty pharmaceutical company dedicated to patients
living with chronic pain, today announced that Herm Cukier, Chief
Executive Officer will present at the Rodman & Renshaw 20th
Annual Global Investment Conference taking place at the St. Regis
Hotel in New York, NY.
Presentation details:
Date:
Thursday – September 6,
2018Time:
4:15 PM Eastern Time
The presentation will be webcast live and can be accessed in
the investor section (events page) of the BDSI
website. For those who are not available to listen to the
live broadcast, a replay of the webcast will be available.
About BioDelivery Sciences
International, Inc.BioDelivery Sciences International,
Inc. (NASDAQ: BDSI) a leading commercial specialty
pharmaceutical company dedicated to patients living with chronic
pain. BDSI is utilizing its novel and proprietary BioErodible
MucoAdhesive (BEMA®) technology and other drug delivery
technologies to develop and commercialize, either on its own or in
partnership with third parties, new applications of proven
therapies aimed at addressing important unmet medical needs.
BDSI's marketed products and those in
development address serious and debilitating conditions such as
chronic pain, breakthrough cancer pain and opioid dependence.
BDSI's headquarters is in Raleigh, North
Carolina.
For more information, please visit or follow
us:
Internet: |
|
www.bdsi.com |
Facebook: |
|
Facebook.com/BioDeliverySI |
Twitter: |
|
@BioDeliverySI |
BUNAVAIL® (buprenorphine and naloxone)
buccal film (CIII) and BELBUCA® (buprenorphine) buccal film
(CIII) are marketed in the U.S. by BioDelivery Sciences. For
full prescribing information and important safety information on
BDSI products please visit www.bdsi.com where the Company
promptly posts press releases, SEC filings, and other
important information or contact the Company at (800)
469-0261. For full prescribing and safety information on
BELBUCA, please
visit www.belbuca.com and for full
prescribing and safety information on BUNAVAIL, please
visit www.bunavail.com.
© 2018 BioDelivery Sciences International,
Inc. All rights reserved.
ContactsMary ColemanVice President, Investor
and Public RelationsBioDelivery Sciences International,
Inc.919-582-9050mcoleman@bdsi.com
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Apr 2024 to May 2024
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From May 2023 to May 2024